The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline

Jack F Hollis, Timothy A McAfee, Jeffrey L Fellows, Susan M Zbikowski, Michael Stark, Karen Riedlinger, Jack F Hollis, Timothy A McAfee, Jeffrey L Fellows, Susan M Zbikowski, Michael Stark, Karen Riedlinger

Abstract

Objectives: State and national tobacco quitlines have expanded rapidly and offer a range of services. We examined the effectiveness and cost effectiveness of offering callers single session versus multisession counselling, with or without free nicotine patches.

Methods: This 3x2 randomised trial included 4614 Oregon tobacco quitline callers and compared brief (one 15-minute call), moderate (one 30-minute call and a follow-up call) and intensive (five proactive calls) intervention protocols, with or without offers of free nicotine patches (nicotine replacement therapy, NRT). Blinded staff assessed tobacco use by phone at 12 months.

Results: Abstinence odds ratios were significant for moderate (OR = 1.22, CI = 1.01 to 1.48) and intensive (OR = 1.29, CI = 1.07 to 1.56) intervention, and for NRT (OR = 1.58, CI = 1.35 to 1.85). Intent to treat quit rates were as follows: brief no NRT (12%); brief NRT (17%); moderate no NRT (14%); moderate NRT (20%); intensive no NRT (14%); and intensive NRT (21%). Relative to brief no NRT, the added costs for each additional quit was $2467 for brief NRT, $1912 for moderate no NRT, $2109 for moderate NRT, $2641 for intensive no NRT, and $2112 for intensive NRT.

Conclusion: Offering free NRT and multisession telephone support within a state tobacco quitline led to higher quit rates, and similar costs per incremental quit, than less intensive protocols.

Conflict of interest statement

Competing interests: JFH, JLF and KR have no competing interests. TAMcA and SMZ are with Free & Clear, Inc, which is a for‐profit company providing telephone counselling services.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2598511/bin/tc19794.f1.jpg

References

    1. Cummins S F, Bailey L, Campbell al Tobacco cessation quitlines in North America: a descriptive study. Tob Control 200716(Suppl I)i9–15.
    1. Miller C L, Wakefield M, Roberts L. Uptake and effectiveness of the Australian telephone Quitline service in the context of a mass media campaign. Tob Control 200312(Suppl 2)ii53–ii58.
    1. Wilson N, Grigg M, Graham al The effectiveness of television advertising campaigns on generating calls to a national quitline by Maori. Tob Control 200514284–286.
    1. Fiore M C, Croyle R T, Curry S al Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health 200494205–210.
    1. Ossip‐Klein D J, McIntosh S. Quitlines in North America: evidence base and applications. Am J Med Sci 2003326201–205.
    1. Centers for Disease Control and Prevention Telephone quitlines: a resource for development, implementation, and evaluation. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004
    1. Fiore M C, Bailey W C, Cohen S alTreating tobacco use and dependence: a clinical practice guideline. Rockville, MD: United States Department of Health and Human Services, 2000
    1. Hughes J R, Shiffman S, Callas al A meta‐analysis of the efficacy of over‐the‐counter nicotine replacement. Tob Control 20031221–27.
    1. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004;CD000031
    1. Gonzales D, Rennard S I, Nides al Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained‐release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 200629647–55.
    1. Jorenby D E, Hays J T, Rigotti N al Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained‐release bupropion for smoking cessation: a randomized controlled trial. JAMA 200629656–63.
    1. Tonstad S, Tonnesen P, Hajek al Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 200629664–71.
    1. Lichtenstein E, Glasgow R E, Lando H al Telephone counseling for smoking cessation: rationales and meta‐analytic review of evidence. Health Educ Res 199611243–257.
    1. Hopkins D P, Briss P A, Ricard C al Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 20012016–66.
    1. Stead L F, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 200716(Suppl I)3–8.
    1. Stead L F, Lancaster T, Perera R. Telephone counseling for smoking cessation. Cochrane Database Syst Rev 200619
    1. Borland R, Segan C J, Livingston P al The effectiveness of callback counseling for smoking cessation: a randomized trial. Addiction 200196881–889.
    1. Zhu S H, Anderson C M, Tedeschi G al Evidence of real‐world effectiveness of a telephone quitline for smokers. N Engl J Med 20023471087–1093.
    1. McAlister A L, Rabius V, Geiger al Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control 20041385–86.
    1. Smith P M, Cameron R, McDonald P al Telephone counseling for population‐based smoking cessation. Am J Health Behav 200428231–241.
    1. Zhu S H, Anderson C M, Johnson C al A centralised telephone service for tobacco cessation: the California experience. Tob Control 20009(Suppl 2)ii48–ii55.
    1. McAfee T, Sofian N S, Wilson al The role of tobacco intervention in population‐based health care: a case study. Am J Prev Med 19981446–52.
    1. Borland R, Balmford J, Segan al The effectiveness of personalized smoking cessation strategies for callers to a quitline service. Addiction 200398837–846.
    1. Zhu S H, Stretch V, Balabanis al Telephone counseling for smoking cessation: effects of single‐session and multiple‐session interventions. J Consult Clin Psychol 199664202–211.
    1. Gilbert H, Sutton S. Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction 2006101590–598.
    1. Swan G E, McAfee T, Curry S al Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 20031632337–2344.
    1. Zhu S H, Tedeschi G, Anderson C al Telephone counseling as adjuvant treatment for nicotine replacement therapy in a “real‐world” setting. Prev Med 200031357–363.
    1. Macleod Z R, Charles M A, Arnaldi V al Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Med J Aust 2003179349–352.
    1. Reid R D, Pipe A, Dafoe W A. Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. CMAJ 19991601577–1581.
    1. Halpin H A, McMenamin S B, Rideout al The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial. Treating Tobacco Dependence 20064354–65.
    1. Solomon L J, Scharoun G M, Flynn B al Free nicotine patches plus proactive telephone peer support to help low‐income women stop smoking. Prev Med 20003168–74.
    1. Cummings K M, Hyland A, Fix al Free nicotine patch giveaway program 12‐month follow‐up of participants. Am J Prev Med 200631181–184.
    1. Tunis S R, Stryer D B, Clancy C M. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 20032901624–1632.
    1. Rollnick S. What is motivational interviewing? Motivational Interviewing Newsletter for Trainers 19952(Issue 3)1–8.
    1. Rollnick S, Miller W. What is motivational interviewing? Behavioral Cognitive Psychotherapy 199523325–334.
    1. Miller W, Rollnick S.Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press, 1991
    1. Schafer J L, Graham J W. Missing data: our view of the state of the art. Psychol Methods 20027147–177.
    1. Solas V. 3.0. Cork, Ireland: Statistical Solutions, Ltd. 2001
    1. US Department of Labor Bureau of Labor Statistics. Available at http:
    1. Fix B, Carlin S, Celestino al Free NRT programs: a report on the reach, efficacy, and cost‐effectiveness of NRT give away programs conducted in New York state, 2004
    1. An L C, Schillo B A, Kavanaugh al Access to nicotine replacement therapy as part of a statewide tobacco telephone helpline. Am J Health Promotion 200620267–271.
    1. Miller N, Frieden T R, Liu S al Effectiveness of a large‐scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 20053651849–1854.
    1. Swartz S H, Cowan T M, Klayman J al Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med 200529288–294.
    1. Cummings K M, Fix B, Celestino al Reach, efficacy, and cost‐effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 20061237–43.
    1. Bush T, Zbikowski S M, McClure al Treatment utilization and adherence in a telephonic tobacco cessation program. Proc National Conference on Tobacco or Health 2003
    1. Hall S M, Delucchi K L, Velicer W al Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome. Nicotine Tob Res 20013193–202.
    1. Glasgow R E, Mullooly J P, Vogt T al Biochemical validation of smoking status: pros, cons, and data from four low‐intensity intervention trials. Addict Behav 199318511–527.
    1. Velicer W F, Prochaska J O, Rossi J al Assessing outcome in smoking cessation studies. Psychol Bull 199211123–41.
    1. Patrick D L, Cheadle A, Thompson D al The validity of self‐reported smoking: a review and meta‐analysis. Am J Public Health 1994841086–1093.
    1. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob Res 20024149–159.
    1. Fu S S, Partin M R, Snyder al Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care 200612235–243.
    1. McAfee T A. Managed care and the state tobacco settlements. Tob Control 20009(Suppl 1)I17
    1. Schroeder S A. What to do with a patient who smokes. JAMA 2005294482–487.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다